Derm-Biome Pharmaceuticals is a biopharmaceutical company focused on developing treatments for skin diseases and conditions. .
Derm-Biome Pharmaceuticals, Inc has raised $328K in total funding. The most recent round was Grant. The last funding was announced in May 2024.
Derm-Biome Pharmaceuticals, Inc's investors include National Research Council of Canada Industrial Research Assistance Program, Natural Sciences and Engineering Research Council of Canada (NSERC).
Derm-Biome Pharmaceuticals, Inc is headquartered in Vancouver, Canada.
Derm-Biome Pharmaceuticals is a biopharmaceutical company focused on developing treatments for skin diseases and conditions. .
Derm-Biome Pharmaceuticals, Inc is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Derm-Biome Pharmaceuticals, Inc — Funding & Investors." VCBacked, May 8, 2024, https://www.vcbacked.co/company/derm-biome-pharmaceuticals-inc. Accessed August 14, 2026.
VCBacked. (2024). Derm-Biome Pharmaceuticals, Inc — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/derm-biome-pharmaceuticals-inc
{{cite web |title=Derm-Biome Pharmaceuticals, Inc — Funding & Investors |url=https://www.vcbacked.co/company/derm-biome-pharmaceuticals-inc |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated